These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38866763)

  • 1. A probe for NIR-II imaging and multimodal analysis of early Alzheimer's disease by targeting CTGF.
    Lu C; Meng C; Li Y; Yuan J; Ren X; Gao L; Su D; Cao K; Cui M; Yuan Q; Gao X
    Nat Commun; 2024 Jun; 15(1):5000. PubMed ID: 38866763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering of donor-acceptor-donor curcumin analogues as near-infrared fluorescent probes for
    Fang D; Wen X; Wang Y; Sun Y; An R; Zhou Y; Ye D; Liu H
    Theranostics; 2022; 12(7):3178-3195. PubMed ID: 35547754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connective tissue growth factor (CTGF) expression in the brain is a downstream effector of insulin resistance- associated promotion of Alzheimer's disease beta-amyloid neuropathology.
    Zhao Z; Ho L; Wang J; Qin W; Festa ED; Mobbs C; Hof P; Rocher A; Masur S; Haroutunian V; Pasinetti GM
    FASEB J; 2005 Dec; 19(14):2081-2. PubMed ID: 16186174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shedding Light on the Molecular Pathology of Amyloid Plaques in Transgenic Alzheimer's Disease Mice Using Multimodal MALDI Imaging Mass Spectrometry.
    Kaya I; Zetterberg H; Blennow K; Hanrieder J
    ACS Chem Neurosci; 2018 Jul; 9(7):1802-1817. PubMed ID: 29648443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging asparaginyl endopeptidase (AEP) in the live brain as a biomarker for Alzheimer's disease.
    Wang SS; Liu ZK; Liu JJ; Cheng Q; Wang YX; Liu Y; Ni WW; Chen HZ; Song M
    J Nanobiotechnology; 2021 Aug; 19(1):249. PubMed ID: 34412639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design synthesis and evaluation of a novel near-infrared fluorescent probe for selective imaging of amyloid-β aggregates in Alzheimer's disease.
    Wang B; Shi J; Guo N; Shao L; Zhai W; Jiang L; Zhao F; Wang J; Wang J; Du L; Pang X; Yan L
    Anal Chim Acta; 2023 Nov; 1281():341900. PubMed ID: 38783740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting.
    Plissonneau M; Pansieri J; Heinrich-Balard L; Morfin JF; Stransky-Heilkron N; Rivory P; Mowat P; Dumoulin M; Cohen R; Allémann É; Tόth É; Saraiva MJ; Louis C; Tillement O; Forge V; Lux F; Marquette C
    J Nanobiotechnology; 2016 Jul; 14(1):60. PubMed ID: 27455834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Activatable NIR-II Fluorescent Reporter for In Vivo Imaging of Amyloid-β Plaques.
    Miao J; Miao M; Jiang Y; Zhao M; Li Q; Zhang Y; An Y; Pu K; Miao Q
    Angew Chem Int Ed Engl; 2023 Feb; 62(7):e202216351. PubMed ID: 36512417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients.
    Kung MP; Skovronsky DM; Hou C; Zhuang ZP; Gur TL; Zhang B; Trojanowski JQ; Lee VM; Kung HF
    J Mol Neurosci; 2003 Feb; 20(1):15-24. PubMed ID: 12663930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer's disease cases.
    Wirths O; Bethge T; Marcello A; Harmeier A; Jawhar S; Lucassen PJ; Multhaup G; Brody DL; Esparza T; Ingelsson M; Kalimo H; Lannfelt L; Bayer TA
    J Neural Transm (Vienna); 2010 Jan; 117(1):85-96. PubMed ID: 19823761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
    Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B
    J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of novel 123I-labeled pyridyl benzofuran derivatives for SPECT imaging of β-amyloid plaques in Alzheimer's disease.
    Ono M; Cheng Y; Kimura H; Watanabe H; Matsumura K; Yoshimura M; Iikuni S; Okamoto Y; Ihara M; Takahashi R; Saji H
    PLoS One; 2013; 8(9):e74104. PubMed ID: 24058519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between amyloid-β and hemoglobin: implications for amyloid plaque formation in Alzheimer's disease.
    Chuang JY; Lee CW; Shih YH; Yang T; Yu L; Kuo YM
    PLoS One; 2012; 7(3):e33120. PubMed ID: 22412990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-plaque conformational changes in Alzheimer's disease-linked Aβ and APP.
    Klementieva O; Willén K; Martinsson I; Israelsson B; Engdahl A; Cladera J; Uvdal P; Gouras GK
    Nat Commun; 2017 Mar; 8():14726. PubMed ID: 28287086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
    Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
    J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Trimodal MALDI Imaging Mass Spectrometry (IMS3) at 10 μm Reveals Spatial Lipid and Peptide Correlates Implicated in Aβ Plaque Pathology in Alzheimer's Disease.
    Kaya I; Brinet D; Michno W; Başkurt M; Zetterberg H; Blenow K; Hanrieder J
    ACS Chem Neurosci; 2017 Dec; 8(12):2778-2790. PubMed ID: 28925253
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Fang D; Pan D; Wen X; Zhang J; Yang M; Ye D; Liu H
    ACS Chem Neurosci; 2024 Feb; 15(3):472-478. PubMed ID: 38214485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential protective effects of connective tissue growth factor against Aβ neurotoxicity on neurons and glia.
    Yang CN; Wu MF; Liu CC; Jung WH; Chang YC; Lee WP; Shiao YJ; Wu CL; Liou HH; Lin SK; Chan CC
    Hum Mol Genet; 2017 Oct; 26(20):3909-3921. PubMed ID: 29016849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological evaluation of the radioiodinated imidazo[1,2-a]pyridine derivative DRK092 for amyloid-β imaging in mouse model of Alzheimer's disease.
    Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Morimoto Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Suhara T; Higuchi M; Yamada K; Ji B
    Neurosci Lett; 2014 Oct; 581():103-8. PubMed ID: 25172571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.